Related Links
Statistics
| Number of Journals | 8 |
| Number of Issues | 52 |
| Number of Articles | 381 |
| Article View | 108,618 |
| PDF Download | 72,949 |
Frontotemporal Dementia and the Therapeutic Void: Bridging the Gap in Drug Development for FTD | ||
| Advances in Pharmacology and Therapeutics Journal | ||
| Volume 5, Issue 2 - Serial Number 9, September 2025, Pages 103-105 PDF (384.45 K) | ||
| Document Type: Editorial Article | ||
| DOI: 10.18502/aptj.v5i2.19459 | ||
| Author | ||
| Mohsen Zabihi* | ||
| Abstract | ||
| Frontotemporal dementia (FTD) is a progressive and early-onset neurodegenerative condition, and there are no approved disease-modifying therapies. Despite growing insight into its molecular pathology and the development of biomarkers and genetic stratification tools, drug development for FTD remains limited. Significant challenges include the clinical and pathological heterogeneity of the disease, difficulties in early diagnosis, and limited commercial incentives due to its relative rarity. This editorial highlights the urgent need for coordinated translational research efforts, international collaboration, and robust funding mechanisms to accelerate therapeutic innovation. While the scientific groundwork is promising, overcoming the current therapeutic void requires sustained and strategic global initiatives. | ||
| Keywords | ||
| Frontotemporal Dementia; Drug Development; Therapeutic Gap; Neurodegeneration; Biomarkers; Translational Research; Precision Medicine | ||
|
Statistics Article View: 17 PDF Download: 11 |
||